Direxion Daily Anthropic Bull & Bear 2X ETFs

The Direxion Daily Anthropic Bull 2X ETF (CLAU) seeks daily investment results, before fees and expenses, of 200% of the daily performance of Anthropic. The Direxion Daily Anthropic Bear 2X ETF (CLAD) seeks daily investment results, before fees and expenses, of 200% of the inverse of the daily performance of Anthropic.

There is no guarantee the Funds will meet their stated investment objectives.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective, and a launch date has not been announced. Sign up for email updates on this page to be notified when the funds begin trading.

A preliminary prospectus is filed with the SEC as part of a fund’s registration statement before it becomes effective. It describes the fund’s investment objective, strategies, risks, charges, and expenses, but the information in it is subject to completion or amendment. Securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

You can read the preliminary prospectus for these funds using the “Read Pre-Prospectus” button above.

No. The Funds seek daily investment objectives and should not be expected to track the underlying security for periods longer than a single day. Holding the Funds for longer than one day can produce returns that differ significantly from 2X (or -2X) the return of the underlying security over the same period, due to the effects of compounding. Investors should actively monitor their investments.

Investing in the Funds involves a high degree of risk. The Funds are not suitable for all investors and should be used only by knowledgeable investors who understand the consequences of seeking daily leveraged (2X) or daily inverse leveraged (-2X) investment results, including the impact of compounding on Fund performance.

Select “Read Pre-Prospectus” in the section above to view it on this page, visit direxion.com, or call 866-476-7523. The preliminary prospectus should be read carefully before investing.